Literature DB >> 11307159

Reactive microglia in dysmyelination and demyelination.

S C Zhang1, B D Goetz, J L Carré, I D Duncan.   

Abstract

The relationship between microglial activation and dysmyelination/demyelination was analyzed in a long-lived myelin mutant, the Long Evans shaker (les) rat, which exhibits early dysmyelination and a later loss of abnormal myelin sheaths. A microglial reaction characterized by progressive morphological transformation and increasing cell density was localized exclusively to white matter during postnatal 2-4 weeks, suggesting a microglial response to dysmyelination and oligodendroglial pathology. A further microglial reaction as marked by microglial expression of MHC II and a concomitant expression in the brain and spinal cord of mRNA for interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha), and inducible nitric oxide synthase (iNOS) began around 4 weeks when the remaining myelin was lost. Ultrastructurally, activated microglia ingested numerous myelin figures, suggestive of active phagocytosis. Thus, this study indicates that microglial reaction is graded in chronic neurological disorders and suggests that MHC II expression marks a functional change of activated microglia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11307159     DOI: 10.1002/glia.1045

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  21 in total

1.  Iron Availability Compromises Not Only Oligodendrocytes But Also Astrocytes and Microglial Cells.

Authors:  Maria Victoria Rosato-Siri; Leandro Marziali; María Eugenia Guitart; Maria Elvira Badaracco; Mariana Puntel; Fernando Pitossi; Jorge Correale; Juana Maria Pasquini
Journal:  Mol Neurobiol       Date:  2017-01-14       Impact factor: 5.590

Review 2.  Neuroprotection in multiple sclerosis: a therapeutic approach.

Authors:  Amir-Hadi Maghzi; Alireza Minagar; Emmanuelle Waubant
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

3.  Transcriptome analysis of mouse brain infected with Toxoplasma gondii.

Authors:  Sachi Tanaka; Maki Nishimura; Fumiaki Ihara; Junya Yamagishi; Yutaka Suzuki; Yoshifumi Nishikawa
Journal:  Infect Immun       Date:  2013-07-15       Impact factor: 3.441

4.  Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure.

Authors:  Sujatha Kannan; Fadoua Saadani-Makki; Bindu Balakrishnan; Pulak Chakraborty; James Janisse; Xin Lu; Otto Muzik; Roberto Romero; Diane C Chugani
Journal:  Dev Neurosci       Date:  2011-07-28       Impact factor: 2.984

Review 5.  The myelin mutants as models to study myelin repair in the leukodystrophies.

Authors:  Ian D Duncan; Yoichi Kondo; Su-Chun Zhang
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 6.  Myelin repair strategies: a cellular view.

Authors:  Vittorio Gallo; Regina C Armstrong
Journal:  Curr Opin Neurol       Date:  2008-06       Impact factor: 5.710

Review 7.  The role of microglia in central nervous system immunity and glioma immunology.

Authors:  Isaac Yang; Seunggu J Han; Gurvinder Kaur; Courtney Crane; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2009-11-18       Impact factor: 1.961

8.  Cellular prion protein participates in the regulation of inflammatory response and apoptosis in BV2 microglia during infection with Mycobacterium bovis.

Authors:  Tianjian Ding; Xiangmei Zhou; Mohammed Kouadir; Fushan Shi; Yang Yang; Jin Liu; Min Wang; Xiaomin Yin; Lifeng Yang; Deming Zhao
Journal:  J Mol Neurosci       Date:  2013-01-24       Impact factor: 3.444

Review 9.  Role of immune cells in animal models for inherited neuropathies: facts and visions.

Authors:  Mathias Mäurer; Igor Kobsar; Martin Berghoff; Christoph D Schmid; Stefano Carenini; Rudolf Martini
Journal:  J Anat       Date:  2002-04       Impact factor: 2.610

10.  Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination.

Authors:  Chelsey M Smith; Elizabeth Cooksey; Ian D Duncan
Journal:  J Neurosci       Date:  2013-02-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.